4-(4-methoxyphenoxy)quinazoline | 93866-13-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-(4-methoxyphenoxy)quinazoline
• 英文别名: 4-(4-methoxy-phenoxy)-quinazoline；4-(4-Methoxyphenoxy)-chinazolin
• CAS: 93866-13-8
• 化学式: C₁₅H₁₂N₂O₂
• 分子量: 252.272
• InChiKey: NQBGCGDJLBSTBJ-UHFFFAOYSA-N

物化性质

• 沸点：
  409.0±25.0 °C(Predicted)
• 密度：
  1.233±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  44.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  4-氯喹唑啉 、 4-甲氧基苯酚 在 sodium hydride 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 5.0h， 以89%的产率得到4-(4-methoxyphenoxy)quinazoline
  参考文献：
  名称：

  [EN] 4-ARYLAMINO-QUINAZOLINES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS
  [FR] COMPOSES ET LEUR UTILISATION THERAPEUTIQUE

  摘要：

  公开号：

  WO2005003100A3

文献信息

• The Scope and Mechanism of Phosphonium-Mediated S_NAr Reactions in Heterocyclic Amides and Ureas
  作者：Zhao-Kui Wan、Sumrit Wacharasindhu、Christopher G. Levins、Melissa Lin、Keiko Tabei、Tarek S. Mansour

  DOI：10.1021/jo7020373

  日期：2007.12.1

  An efficient “one-step” synthesis of cyclic amidines and guanidines has been developed. Treatment of cyclic amides and ureas with benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP), base, and nitrogen nucleophiles leads to the formation of the corresponding cyclic amidines and guanidines, typically in good to excellent yields. This method has also been used to prepare heteroaryl

  已经开发了有效的“一步”合成环状am和胍的方法。用六氟磷酸苯并三唑-1-基氧基三（二甲氨基）phosph，碱和氮亲核试剂处理环状酰胺和脲会导致形成相应的环状typically和胍，通常收率高至优异。该方法也已经用于使用苯酚和硫代苯酚亲核试剂制备杂芳基醚和硫醚。时程NMR和HPLC-MS研究促进了所提出的中间体（phospho盐和HOBt加合物）的明确表征。数据揭示了逐步的反应途径。
• HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION
  申请人：Mansour Tarek Suhayl

  公开号：US20090291971A1

  公开（公告）日：2009-11-26

  The present invention relates to processes for the preparation of heteroaryl ethers. In some embodiments, the processes relate to cross coupling reactions between triazol-1-yloxy and triazol-1-yl heterocycles with aryl boronic acids. In a further aspect, this invention also relates to compounds that are useful for the treatment of oncological diseases or disorders, and for the treatment of inflammation.

  本发明涉及制备杂环基醚的过程。在某些实施例中，该过程涉及三唑-1-氧基和三唑-1-基杂环与芳基硼酸之间的交叉偶联反应。在进一步的方面，本发明还涉及用于治疗肿瘤疾病或障碍以及治疗炎症的化合物。
• COMPOUNDS AND THERAPEUTICAL USE THEREOF
  申请人：Cai Xiong Sui

  公开号：US20070244113A1

  公开（公告）日：2007-10-18

  Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  本发明揭示了4-芳氨基喹唑啉及其类似物，可有效激活半胱氨酸蛋白酶并诱导细胞凋亡。本发明的化合物在治疗各种临床情况中具有用途，其中异常细胞的不受控制的生长和扩散。
• Compounds and therapeutical use thereof
  申请人：Cai Xiong Sui

  公开号：US20050137213A1

  公开（公告）日：2005-06-23

  Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  本发明揭示了4-芳基氨基喹唑啉及其类似物，它们有效地激活半胱氨酸蛋白酶并诱导细胞凋亡。本发明的化合物在治疗各种临床病症中具有用途，其中发生异常细胞的不受控制的生长和扩散。
• 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
  申请人：Myriad Pharmaceuticals, Inc.

  公开号：US07618975B2

  公开（公告）日：2009-11-17

  Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  本发明揭示了4-芳基氨基喹唑啉及其类似物，其作为caspase激活剂和诱导凋亡剂具有有效性。本发明的化合物在治疗各种临床病症中有用，其中发生异常细胞的不受控制的生长和扩散。